IP Library Granted Patent US 9,279,103
Granted Patent B2
US 9,279,103 · App. 13/204,354 · Granted Mar 8, 2016

Simplified basic media for human pluripotent cell culture

Inventors: Guokai Chen (Rockville, MD); James A. Thomson (Madison, WI)
Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
C12N5/0606C12N5/0696C12N2500/25C12N2500/38C12N2500/92C12N2500/98C12N2501/115C12N2501/15C12N2501/39C12N2501/727C12N2501/999
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,279,103
App. No.
13/204,354
Granted
Mar 8, 2016
Kind
B2
Abstract

Fully defined media that support pluripotent cell viability, proliferation, cloning, and derivation, as well as methods and compositions including these media are described. Methods for deriving iPS cells from adult individuals under defined, xeno-free conditions are also described.

Claims (23)

1. A defined, albumin-free medium free of any component obtained from a non-human animal, the medium comprising water, salts, amino acids, vitamins, glucose, insulin, an FGF, selenium, transferrin, and one of TGF-β and NODAL, each in an amount sufficient to support human pluripotent stem cell proliferation.

2. A method for culturing human pluripotent stem cells, the method comprising the steps of:

placing pluripotent stem cells on a matrix; and

contacting the cells with a defined, albumin-free medium free of any component obtained from a non-human animal, the medium comprising water, salts, amino acids, vitamins, glucose, insulin, an FGF, selenium, transferrin, and one of TGF-β and NODAL, each in an amount sufficient to support human pluripotent stem cell proliferation.

3. The method of claim 2 , wherein the matrix comprises laminin.

4. The method of claim 2 , wherein the matrix comprises vitronectin.

5. The method of claim 2 , wherein the cells are contacted with the medium under hypoxic conditions.

6. The method of claim 2 , wherein the pluripotent stem cells are embryonic stem cells.

7. The method of claim 2 , wherein the pluripotent stem cells are induced pluripotent stem cells.

8. A method for cloning a human pluripotent stem cell, the method comprising the step of:

plating human pluripotent stem cells at cloning density in a defined albumin-free medium free of any component obtained from a non-human animal, the medium comprising water, salts, amino acids, vitamins, glucose, insulin, an FGF, selenium, transferrin, and one of TGF-β and NODAL, each in an amount sufficient to support human pluripotent stem cell cloning.

9. The method of claim 8 , wherein the medium further comprises a ROCK inhibitor.

10. The method of claim 9 , wherein the ROCK inhibitor is selected from the group consisting of HA100 and Y27632.

11. The method of claim 8 , wherein the medium further comprises blebbistatin.

12. A method of cryopreserving human pluripotent stem cells, the method comprising the step of:

freezing human pluripotent stem cells in a defined, albumin-free medium free of any component obtained from a non-human animal, the medium comprising water, salts, amino acids, vitamins, glucose, insulin, an FGF, selenium, transferrin, and one of TGF-β and NODAL, each in an amount sufficient to support human pluripotent stem cell proliferation.

13. The defined, albumin-free medium of claim 1 , consisting essentially of: water, salts, amino acids, vitamins, glucose, insulin, an FGF, selenium, transferrin, and one of TGF-β and NODAL.

14. The defined, albumin-free medium of claim 1 , wherein the medium comprises TGF-β.

15. The defined, albumin-free medium of claim 1 , wherein the medium comprises NODAL.

16. The defined, albumin-free medium of claim 1 , further comprising a ROCK inhibitor.

17. The defined, albumin-free medium of claim 16 , wherein the ROCK inhibitor is selected from the group consisting of HA100 and Y27632.

18. The defined, albumin-free medium of claim 1 , further comprising blebbistatin.

19. The defined, albumin-free medium of claim 1 , consisting of: water, salts, amino acids, vitamins, glucose, insulin, an FGF, selenium, transferrin, and one of TGF-β and NODAL.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2012
From: THOMSON, JAMES; CHEN, GUOKAI
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 029253/0434 →
CONFIRMATORY LICENSE Recorded Sep 2, 2011
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026848/0756 →
Continuity (1)
Related Publication 20120202291A1 · Aug 9, 2012